{
    "2020-02-17": [
        [
            {
                "time": "",
                "original_text": "高瓴资本8折独吞凯莱英23亿元定增，这个“卖铲子”的行业为何让资本汹涌而至？",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "凯莱英",
                        "定增",
                        "资本涌入"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "资本"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "高瓴资本加持 凯莱英能走多远？",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "凯莱英"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "瑞德西韦等初步显示良好临床疗效 两上市公司获批参与",
                "features": {
                    "keywords": [
                        "瑞德西韦",
                        "临床疗效",
                        "上市公司"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "昨晚，高瓴火速出手：23亿元，再融资新规首例诞生！",
                "features": {
                    "keywords": [
                        "高瓴",
                        "再融资",
                        "新规",
                        "23亿元"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "资本",
                        "政策"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}